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Abstract 
Alcohol remains the single most significant cause of liver disease throughout the Western world; which is 
responsible for about 40 – 80% cause of cirrhosis in different countries. This study was therefore carried out to 
investigate the sero-prevalence of HBV infection among alcoholics. One hundred and thirty eight (138) alcoholic 
consumers and fifty (50) control subjects at Billiri Community in Billiri Local Government Area of Gombe State 
were screened for HBsAg using Clinotech Diagnostic Third Generation ELISA Kit. Structured questionnaire 
was employed to obtain demographic data of study subjects.The result obtained showed a positivity of 10 (5.3%) 
among the subjects screened. Considering gender 7 (3.7%) seropositivity was recorded among the alcoholic 
males compared to 3 (2.1%) in females. Age consideration showed that subjects within 21 – 30 years recorded 4 
(2.1%) prevalence. Equally control subjects had a prevalence of 4 (2.1%). Considering the serum amino 
transferase (ALT) among positive subjects screened 8 (4.3%) recorded an elevated ALT.The data obtained in 
this study calls for drastic measures at curtailing the spread of this virus, because of its attendant effects on the 
liver. Also, immunization of individuals in this community is highly recommended. 
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1. Introduction 
Hepatitis B virus infects the liver of the hominidae including humans and causes an inflammation called hepatitis. 
It is a DNA virus and one of the unrelated viruses that cause viral hepatitis. The disease was originally known as 
“serum” hepatitis (Barker et al., 1996) and has caused epidemics in parts of Asia and Africa. Hepatitis B is 
endemic in China and various other parts of Asia (Williams, 2006). The proportion of the world’s population 
currently affected with the estimated at 3% - 6%. Symptoms of the acute illness caused by the virus include liver 
inflammation, vomiting, jaundice and rarely death. Chronic hepatitis B may eventually cause liver cirrhosis and 
liver cancer, a fatal disease with very poor response to current chemotherapy (Chang, 2007). The infection is 
prevented by vaccination (Pungpapong et al., 2007). 
Hepatitis B virus infection is estimated to be the cause of 30% of cirrhosis and 53% of liver cancer in the 
world,(Perz,2008).Approximately 15-40% of patients with chronic HBV will develop cirrhosis, end-stage 
liver 
 
failure or hepatocellular carcinoma (HCC) in their lifetime,(Lok 2002).Most of the deaths (94%) were 
attributed to complications. Chronic infection, such as cirrhosis and HCC, and only 6% were attributed directly 
to acute Hepatitis B, (Goldstien,et al,2002).Hepatocellular carcinoma is the sixth most common 
 
cancer and the 
third most common cause of cancer death in the world,(Ferly,et al 2010).Chronic HBV infection is the most 
common cause of HCC, accounting for 50% of HCC cases worldwide 
 
and up to 80% of cases in high HBV 
endemic regions,(Bosch,et al 2004). The risk of the world’s population live in areas of low endemicity, 
developing HCC is 
 
greatly increased with the development of cirrhosis. Thus, the ideal way to decrease HBV-
related deaths is to first prevent the infection through vaccination and strategies to reduce transmission and 
second, to prevent progression to cirrhosis and HCC in those already infected.
 
 
 Hepatitis B virus infection may either be acute (self-limiting) or chronic (long standing), persons with 
self-limiting infection clear the infection, more than 95% of people who become infected as acute or older 
children will stage a full recovery and develop protective immunity to the virus. However only 5% new born that 
acquire the infection from their mother at birth will clear the infection. Those infected between the age of 1 – 6 
years, 70% will clear the infection (Kerkar, 2005). 
 The liver which is the largest visceral organ, the most versatile organ in the body and any condition that 
severally damages the liver represent a serious threat to life as it affects almost every other system of the body. 
Liver has many functions which are vital to survival, they include: - Transformation of food into usable body 
chemicals, filtration of waste bacteria, poison from the blood, haematologic regulation, synthesis and secretion 
of bile and drug inactivation (detoxification). The liver also function as a store house for various minerals, 
vitamins and sugar that the body uses for energy (AIE, 2002). As a result of these functions, the liver is very 
vital to survival. A normal liver is smooth and firm to touch but progressive liver damage can lead to fibrosis, 
shrinkage and hardening and formation of nodules (NATAP, 2002). Liver injury and damages such as hepatitis, 
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fibrosis, cirrhosis, portal hypertension, hepatocellular failure and hepatocellular carcinoma are caused by various 
factors such as toxins (e.g. drugs, alcohol, poison and chemicals) and infective agents (e.g. some viruses, bacteria, 
parasite) (Abdalla, 2001; Martin et al., 2000). 
Several epidemiologic studies suggest that chronic alcoholics are at risk of viral infections. Clinical and basic 
research has demonstrated that alcohol not only worsens the natural history of chronic viral hepatitis, like 
hepatitis B virus (HBV) but also seems to interact with the viral replication cycle leading to an unusual serum 
virologic profile and/or modification in the serum concentration of viral particles (Nalpas et al., 1998). Several 
studies  have shown that patients with alcoholic cirrhosis showed evidence of past or current infection with HBV 
more commonly than did healthy nonalcoholic subjects (Bassendine et al., 1983, Goudeau et al., 1981, Inoue, 
1977 and Mills et al., 1981). 
An alcoholic has been defined as one who consumes more of alcohol i.e. 5 fluid oz of wine or 1.5 fluid ounce (oz) 
of distilled spirits and contain approximately 0.5 oz (14 grams) of pure alcohol and these level represents heavy 
alcohol intake and typically alcohol abuse (Lieber, 2001; Peters et al., 2002) chronic alcohol intake is the most 
frequent cause of liver disease and accounts for majority estimated 100,000 alcohol related deaths each year 
(NIAAA, 1998; Abdalla, 2001). Alcohol affects many organ including the liver (AIE, 2002). Any one who 
consumes excessive amount of alcohol will have liver damage, but may not always develop into cirrhosis.  
 Several vaccines have been developed for the prevention of hepatitis B virus infection. These rely on 
the use of one of the viral enveloped protein (hepatitis B surface antigen). The vaccine was originally prepared 
from plasma obtained from patients who had long-standing hepatitis B virus infection. However, recombinant 
DNA technology through plasma derived vaccines is equally effective and safe (Zuckerman, 2006). Hepatitis B 
surface antigen may be detected in serum for several days; this is known as vaccine antigenaemia (Martin-Abcel, 
et al., 2004).Prevention of the transmission of viral hepatitis should focus on public enlightenment campaign to 
prevent transmission to others and protection of those at risk group against the virus. (De Palma, 2002). 
 
2. Methodology: 
2.1. Study Design: Alcoholic consumers in a local community North- eastern Nigeria were recruited for this 
study. The study ensured that only volunteers who agreed to alcoholic consumption at various stages of life were 
recruited for the study. 
2.2. Enrolment and Data Collection: After obtaining in- formed consent, volunteer subjects completed a 
questionnaire which was based mainly on the knowledge of risk of exposure. These questionnaires were 
distributed and ﬁlled by subjects through the help of guides where ever necessary. Ethical clearance was then 
obtained from relevant ethical committee before sampling commenced. 
2.3 Sample collection: 3ml of venous blood was collected, duly labeled and allowed to clot and sera carefully 
separated into cryovials and stored at -20
o
C prior use. 
2.4 Sample assay/Analytical process: This was carried out using the HBsAg EIA, which is a solid –phase 
simultaneous sandwich immune assay, which employs monoclonal antibodies specific for HBsAg. Microtiter 
well is coated with monoclonal antibodies specific for HBsAg. A serum specimen is added to the antibody 
coated microtiters wells together with enzyme conjugated polyclonal antibodies. 
2.5 HBsAg Testing: 
 Clinotech Diagnostics HBsAg EIA 3
RD
 Generation was used for the detection of HBsAg in 
serum.(Procedures employed in the Assay were based on manufacturers instructions). 
Principles: 
The HBsAg EIA is a solid –phase simultaneous sandwich immune assay, which employs monoclonal 
antibodies specific for HBsAg. Microtiter well are coated with monoclonal antibodies specific for HBsAg. A 
serum specimen is added to the antibody coated microtiters wells together with enzyme conjugated polyclonal 
antibodies. HBsAg, if present, will form a antibody-HBsAg-antibody-enzymes complex. The plate is then 
washed to remove unbound materials. Finally, a solution of HRP enzyme substrate (TMB) is added to the wells 
and incubated. A blue colour will develop in proportion to the amount of HBsAg present in the specimen. The 
enzyme substrate reaction can stopped  and the result is visualized by naked eye or read by EIA plate reader for  
absorbance at the wavelength of 450nm. 
Preparation:  
Test sample, control, conjugate, distilled water, substrate aluminum bag  containing tetramethyl 
benzidine (TMB) were allowed to stand to ambient  temperature before used. 
Assay:      
It was strongly advised to analyze each specimen and control in duplicate. All the reagents should 
equilibrate to room temperature before used. 
1. 50ul  was  dispensed  on  positive   as  well  as  negative  control  in  duplicate  into  respective  
wells. Blank  was  set  as  a  background  control, and  50ul  of  serum  or  plasma  samples  into  
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the  respective  wells. 
2. 50ul  Enzyme  conjugate  was  added  to  each  well-mixed  gently  by  swirling  the  microtiter  
plate  on  the  bench  for  2  minutes.  DO  NOT  ADD  ENZYME  CONJUGATE  TO  THE  
BLANK  WELL. 
3. Incubate at 37
o
C for 1 hour (60 minutes). 
4. Each  well  was  washed  5 times  by  filling  each  well  with  diluted  wash  buffer, then  inverting  
the  plate  vigorously  to  get  all  water  out  and  blocking  the  rim  of  the  wells  on  absorbent  
paper  for  a  few  seconds. 
5. 100ul substrate solution(TMB)  was  added  to each  well, then  incubated  at  37
o
C  for  15  
minutes. 
6. 50ul stop solution was added to each well to stop the color reaction. Read O.D at 450nm and 
630nm with an EIA plate reader within 10 minutes. 
Assay validity: 
Using the O.D value of the blank well to correct all the O.D reading from the wells, OD value of 
positive control should be more than 1.0 and of negative control less than 0.1. Otherwise, the test is invalid. 
Interpretation of result: 
Positive (p) 
The ration of        OD value of sample  > 2.1 
  OD value of negative control 
  Negative (N) 
The ration of          OD value of sample  <2.1 
       OD value of Negative control             
Where 
N= The mean absorbance of the negative controls. 
P= The mean absorbance of the positive controls. 
S=  The absorbance of the test sample. 
If the OD value of the Negative control is less than 0.05, it should be reported as 0.05. If it is more than 
0.05, it should be reported that as the actual OD value measured. 
Calculation of cut-off value: 
The cut-off value is 2.1xNegative (N) 
Test result: 
 A Test is positive if S > cut off value 
 A Test is Negative if S < cut off value.  
2.6 Statistical Analysis. Data from all questionnaires obtained were entered into SPSS, version 16, and analyzed. 
While level of signiﬁcance was set at P<0.05.  
 
3. Results 
 Table 1: Show the distribution of HBV among alcoholics and non-alcoholic subjects. Highest 
prevalence of 10 (5.3%) was recorded, out of a total of 138 alcoholic subjects screened while 4 (2.1%) among 
the non-alcoholic (control) subjects.  
Table 2: The age distribution among alcoholic showed subject aged 21 – 30 years recording the highest 
seroprevalence with 4 (2.9%) while the lowest prevalence of 1 (0.7%) was recorded among those aged 51 – 60 
years. 
Table 3: show the prevalence of HBV based on gender among alcoholic subjects. The highest prevalence of 
HBV among alcoholics was recorded among male subjects with 7 (5.1%) while the female subjects 3 (2.1%). 
Table 4: Risk factors put into consideration among alcoholic subjects showed that subjects with history of blood 
transfusion recorded 3 (1.6%) prevalence. Similarly risk factors based on subjects with history of surgery 
showed a record of 1 (2.5%), with P-value of P<0.05 or P>0.05. 
Table 5: showed risk factor among control (Non-alcoholic) subjects those with history of blood transfusion 
recorded 3 (25.0%) positivity. 
Table 6: The serum aninotransferase level recorded were based on the 14 (7.4%) HBsAg positive samples, 10 
(5.4%) showed a slight elevation of liver enzyme while 4(1.4%) recorded normal level. 
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Table 1:Total Number of Subjects screened. 
Status of subjects 
screened 
Total No of subjects 
screened (%) 
Total No of Positive 
Subjects (%) 
Total of Negative 
Subjects (%) 
Alcoholics 138 (73.4) 10 (5.3) 128 (68.1) 
Non-alcoholics (Control 
group) 
50 (26.6) 4 (2.1) 46 (24.5) 
Total 188 (100) 14 (7.4)  174 (92.6) 
X
2
 = 0.305, df = 1, P =0.823,      P-value < 0.05  
Table 2: Age distribution of HBV infection among alcoholic subjects screened 
Age range Total No of subjects 
screened (%) 
Total No of Positive 
Subjects (%) 
Total of Negative 
Subjects (%) 
21 – 30 50 (36.2) 4 (2.9) 46 (33.3) 
31 – 40 35 (25.4) 2 (1.5) 33 (23.9) 
41 – 50 26 (18.8) 2 (2.14) 25 (18.2) 
51 – 60 20 (14.5) 1 (0.7) 18 (13.0) 
61 – 70 7 (5.1) 1 (0.7) 6 (4.3) 
Total  138 (100) 10 (7.3) 128 (92.7) 
X
2
 = 0.459, df = 2,  P values = 0.795, P-value > 0.05  
Table 3: Distribution of HBV Prevalence based on gender among (Alcoholic) subjects. 
Gender Total No of subjects 
screened (%) 
Total No of Positive 
Subjects (%) 
Total of Negative 
Subjects (%) 
Males 88 (63.8) 7 (5.1) 81 (58.7) 
Females 50 (36.2) 3 (2.1) 47 (34.1) 
Total 138 (100) 10 (7.2) 128 (92.8) 
X
2 
= 0.128, df = 1, P –values = 0.720,   P-value > 0.05  
Table 4: Risk factors based on clinical history of Alcoholic subjects 
Risk Factors Total No of subjects 
screened (%) 
Total No of Positive 
Subjects (%) 
Total of Negative 
Subjects (%) 
History of Blood 
transfusion 
35 (18.6) 3 (1.6) 32 (17.0) 
History of Surgical 
Operation 
15 (8.0) 1 (0.5) 14 (7.5) 
Total 50 (26.6) 4 (2.1) 46 (24.5) 
X
2 
= 0.052, df = 1, P value = 0.820, P-value <0.05 
 Table 5: Risk factors based on clinical history of control (Non-alcoholic) subjects 
Risk Factors Total No of subjects 
screened (%) 
Total No of Positive 
Subjects (5) 
Total of Negative 
Subjects (%) 
History of Blood 
transfusion 
8 (16.0) 3 (6.0) 5 (10.0) 
History of Surgical 
Operation 
4 (8.0) 1 (2.0) 3 (6.0) 
Total 12 (24.0) 4 (8.0) 8 (16.0) 
X
2 
= 0.188 , df = 1, P value = 0.665, P-value > 0.05  
Table 6: Determination based on total subject of serum transaminase level on positive subjects. 
Status of 
subjects 
Total No of 
Subject (%) 
AST 
Abnormal (%) 
AST 
Normal (%) 
ALT 
Abnormal 
(%) 
ALT 
Normal (%) 
Alcoholic 10 (5.3) 8 (4.3) 2 (1.0) 8 (4.3) 2 (1.0) 
Non-Alcoholic 4 (2.1) 2 (1.1) 2 (1.0) 0 (0.0) 4 (2.1) 
Total 14 (7.4) 10 (5.4) 4 (2.0) 8 (4.3) 6 (3.1) 
 
5. Discussion 
 The result obtained showed that the frequency of HBV infection in alcoholics in the community is 
higher than in non-alcoholics. However, active infection (HBsAg positive) was higher in the individuals with 
history of alcoholism than in those without such case history or control subjects. Highest prevalence rate of 10 
(5.3%) out of 138 subjects screened was recorded among the alcoholics while 4 (2.1%) was recorded among the 
non-alcoholic subjects screened (Table I). Statistical analysis showed an insignificant value in both groups (P-
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value = 0.823). These findings agrees with the work of Jerrells et al., (2002) that alcoholism has a part to play in 
viral hepatitis, since prevalence was higher in key subjects than in controls,the reason may be from the different 
substances such as alcohol (Dunn et al., 2005; Jennifer, 2006), which can cause viral hepatitis.According to 
Bedogni, et al., 2008HBV infection in alcoholic is associated with faster progression in liver injury with an 
elevated isk of developing cirrhosis in another study conducted by Laskus, . et al., 1992 among alcoholics it was 
found that prevalence of HBV is estimated to be four fold higher than in controls. 
 Considering age group, the highest prevalence of 4 (2.9%) was recorded among the age 21 – 30 years, 
while the lowest 1 (0.7%) was recorded among those age 51 – 60 years (Table II).Statistical analysis  between 
the age groups indicated no significant differences with P-value 0.795 (i.e. P-value<0.05),The age group 
considered to have the highest prevalence in this study, agrees with the work of Ndako et al 2009 in a similar 
studies conducted among alcoholics, this could also be attributed to youthful exuberance  and hyperactivity 
among this age group. 
            Considering gender, a higher prevalent was observed among males with 7 (5.1%) while female 3 (2.1%) 
prevalent rate. This result corresponds to the work of Kradjen et al., (2005) who report that the prevalence of 
HBsAg depending on the cause is found higher in males than in females; also it in agreement with the report of 
Ndako et al., 2009,  where a higher prevalence was recorded among male subjects screened. This might also be 
attributed to that fact that men in this locality consumed the local brew as stimulants before embarking on 
several activities such as farming and others social functions. Hepatitis B infection might influence the 
development of liver disease in heavy drinkers in several ways. Firstly, persistent infection with HBV might 
potentiate alcohol-induced liver damage, and there is evidence that this may occur at fairly low alcohol intakes 
(Villa et al., 1982). Secondly, chronic active hepatitis associated with HBsAg may coexist with alcoholic liver 
disease, and the two disease processes would probably result in more rapid progression to cirrhosis. 
    The serum amino transferase levels recorded were based on the 14 (7.4%) HBsAg positive samples screened, 
controls inclusive of these 10 (5.4%) showed a slight elevation of liver enzyme; Bellentani et al., (1997) reported 
similar findings which shows a sporadic alteration of liver enzymes level among the positive subjects screened. 
However, according to Gamen et al., (2004) persistent elevation of serum ALT for more than six months 
indicates progression to chronic hepatitis. 
 
Conclusion: 
In conclusion, Hepatitis B infection might influence the development of liver disease in heavy drinkers in several 
ways, this could be due to the fact  that persistent infection with HBV might potentiate alcohol-induced liver 
damage, and there is evidence that this may occur at fairly low alcohol intakes (Villa et al., 1982).Equally 
chronic active hepatitis associated with HBsAg may coexist with alcoholic liver disease, and the two disease 
processes would probably result in more rapid progression to cirrhosis.From our studies,vaccination of subjects 
is strongly advocated in this community,while enlightenment on the dangers of this infectious agent be given 
considerable attention so as to reduce the consequences of this viral infection among the populace. 
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